Table 4 Univariable and multivariable cox-regression analyses for PET-CT and MRI parameters and FIGO stage for predicting progression/recurrence free survival in cervical cancer patients
From: The prognostic value of preoperative FDG-PET/CT metabolic parameters in cervical cancer patients
Variables | Test of Progression/Recurrence free survival | HR | 95% CI | P-value | HR | 95% CI | P-value |
|---|---|---|---|---|---|---|---|
Univariable | Multivariable | ||||||
SUVmax | ≥ 16.0 vs. <  16.0 | 4.2 | 0.5–32.9 | 0.17 |  |  |  |
MTV | ≥ 56.7 mL vs. <  56.7 mL | 7.8 | 2.1–29.5 | 0.002 | 7.8 | 1.2–47.6 | 0.025 |
TLG | ≥ 412 g vs. <  412 g | 6.9 | 1.8–26.0 | 0.004 | 7.5 | 0.7–80.7 | 0.09 |
FIGO stage | ≥ III A vs. < II B | 6.9 | 1.8–26.47 | 0.004 | 5.5 | 1.3–23.0 | 0.020 |
MRI LD | ≥ 37.6 vs. <  37.6.0 | 5.2 | 0.6–40.4 | 0.11 |  |  |  |
MRI TV | ≥ 36.0 mL vs. <  36.0 mL | 4.6 | 1.2–17.0 | 0.022 | 0.6 | 0.1–4.1 | 0.66 |